Glucotrack (GCTK) Non-Current Assets (2010 - 2026)
Glucotrack's (GCTK) quarterly Non-Current Assets came in at $114000.0 in Q2 2026, down 14.29% on a YoY basis from $133000.0 in Q2 2025, and down 33.33% quarter-over-quarter from $171000.0 in Q4 2025.
Powered by 
Analysis
Glucotrack (GCTK) Non-Current Assets (2010 - 2026) Analysis & Trends
Glucotrack (GCTK) has reported Non-Current Assets for 17 consecutive years, with $114000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 14.29% year-over-year to $114000.0; the trailing twelve-month figure through Jun 2026 stood at $602000.0 (down 5.64% YoY), and the FY2025 full-year result was $171000.0, up 4.27% from the prior year.
- Non-Current Assets eased to $114000.0 in Q2 2026 per GCTK's latest filing, from $171000.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $184000.0 in Q3 2024 and bottomed at $26000.0 in Q3 2023.
- Historically, Non-Current Assets has averaged $114705.9 across 5 years, with a median of $128000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets plunged 68.67% in 2023, then jumped 607.69% in 2024.
- Over 5 years, Non-Current Assets stood at $59000.0 in 2022, then slumped by 37.29% to $37000.0 in 2023, then soared by 343.24% to $164000.0 in 2024, then gained by 4.27% to $171000.0 in 2025, then slumped by 33.33% to $114000.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $114000.0, $171000.0, and $184000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Glucotrack | 1.08 Mn | -45,410.46 | - | 114,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114,000.00 |
| Dec 31, 2025 | 171,000.00 |
| Sep 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 93,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 214,000.00 |
| Jun 30, 2021 | 295,000.00 |